79 results
8-K
MREO
Mereo Biopharma Group Plc
23 May 24
Submission of Matters to a Vote of Security Holders
4:16pm
against
% of sharesvoted
Votes withheld
Resolution 3
That the Company’s Audit and Risk Committee be authorized to determine PwC’s remuneration.
Vote
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
, action, suit, audit, survey, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental
10-Q
2024 Q1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
costs
Accrued legal fees
Accrued bonus
Accrued audit fees
Accrued professional fees
Accrued local taxes
Other accrued expenses
Total
10. Convertible
10-Q
2024 Q1
EX-31.1
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit and risk committee of the registrant’s board
10-Q
2024 Q1
EX-31.2
MREO
Mereo Biopharma Group Plc
15 May 24
Quarterly report
4:19pm
evaluation of internal control over financial reporting, to the registrant’s auditors and the audit and risk committee of the registrant’s board
DEF 14A
s9hv7mx t2
24 Apr 24
Definitive proxy
7:30am
10-K
EX-31.1
3uyr0
27 Mar 24
Annual report
5:20pm
10-K
EX-10.30
8swyqub six
27 Mar 24
Annual report
5:20pm
10-K
9tdl22yo7gw3f8s
27 Mar 24
Annual report
5:20pm
10-K
EX-31.2
suh1cb3off1 ee
27 Mar 24
Annual report
5:20pm
6-K
59dpbbglg
20 Sep 23
Current report (foreign)
4:03pm
6-K
rlse1
10 Nov 22
Current report (foreign)
4:06pm
6-K
EX-99.2
bdu5z2a41nzpo64iv
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.2
tcwnha7if4gvjboa35o
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
jxywkrzpipbbqzd 7g7t
26 May 22
Current report (foreign)
4:11pm